Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients. Drawing on 25 years of research, Amytrx is harnessing the power of novel anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases. Our lead therapeutic candidate, AMTX-100, is bioengineered from human protein sequences that modulate the immune system by a natural process, reducing pathogenesis in a range of chronic diseases mediated by excessive inflammation. Joining forces with institutions for clinical research, Amytrx Therapeutics is dedicated to transforming the conventional treatment of chronic inflammatory diseases using biological technology that is easily understood by the human body in a way that is safe, effective, and simple to use.
View Top Employees from Amytrx Therapeutics, Inc.Website | https://www.amytrx.com/ |
Employees | 4 (3 on RocketReach) |
Phone | (615) 383-6166 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
Competitors | ActivX Biosciences, Applied Therapeutics Inc, Ember Therapeutics, Moerae Matrix, Inc., VG Life Sciences |
SIC | SIC Code 283 Companies, SIC Code 87 Companies, SIC Code 873 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies |
Looking for a particular Amytrx Therapeutics, Inc. employee's phone or email?
Danny Helton is the Vice President Chemistry and Manufacturing of Amytrx Therapeutics, Inc..
3 people are employed at Amytrx Therapeutics, Inc..
Amytrx Therapeutics, Inc. is based in Nashville, Tennessee.
The NAICS codes for Amytrx Therapeutics, Inc. are [3254, 32541, 325, 541, 32, 54].
The SIC codes for Amytrx Therapeutics, Inc. are [283, 87, 873, 28].